세계의 유방 병변 위치결정 시장 예측(-2028년) : 유형(와이어, 방사성동위원소, 자기, 전자파), 용도, 최종사용자별

Breast Lesion Localization Market by Type (Wire, Radioisotope, Magnetic, Electromagnetic Localization), Usage, End User - Global Forecast to 2028

US $ 4,950 ￦ 6,991,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,393,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,511,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,125,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 유방 병변 위치결정 시장 규모는 2023년 3억 달러에서 예측 기간 중 6.9%의 CAGR로 추이하며, 2028년에는 4억 달러 규모에 달할 것으로 예측되고 있습니다.

맘모그래피에 의한 유방암 검진의 증가나 영상 기술의 향상에 의해 촉지불능 임상적 불현성 잠인성 유방 병변의 발견이 증가하고 있으며, 주술기 위치결정이 필요하게 되고 있습니다.

용도별로는 유방 생검 부문이 2022년에 큰 점유율을 보이고 있습니다. 이 부문의 큰 점유율은 세계에서 유방 생검을 선택하는 환자가 증가하고 있는 것, 검진 프로그램에서 발견되는 촉지불능 유방 병변의 비율이 증가하고 있는 것, 유방암 검진 프로그램의 수가 증가하고 있는 것, 유방암의 이환율이 증가하고 있는 것, 조기 암발견에 대한 의식이 높아지고 있는 것 등에 기인하고 있습니다.

유형별로는 전자 위치결정 부문이 예측 기간 중 최대의 CAGR을 나타낼 전망입니다. 이 부문의 고성장은 수술 지연의 감소, 환자 만족도의 향상, 최적의 수술 계획, 방사성 성분이 불필요한 것 등의 요인에 의한 것으로 생각되고 있습니다.

또한 지역별로는 아시아태평양이 예측 기간 중 최대의 CAGR로 성장할 전망입니다. 이 시장의 성장을 촉진하는 주요 요인은 유방암 유병률의 상승, 헬스케어 지출의 증가, 아시아태평양 국가에서 유방암 조기 발견을 위한 계발 프로그램의 증가입니다. 또한 유방암 연구에 대한 정부지출의 증가, 자금 제공의 증가도 이 지역의 시장 성장을 지원하고 있습니다.

세계의 유방 병변 위치결정 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 기술·특허의 동향, 사례 연구, 법규제·상환 환경, 시장 규모의 추이·예측, 각종 구분·지역/주요 국가별 상세 분석, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

제5장 시장 개요

• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회
  • 과제

제6장 산업 인사이트

• 산업 동향
• 경제 불황이 유방 병변 위치결정 시장에 미치는 영향
• 밸류체인 분석
• 상환 분석
• 기술 분석
• 공급망 분석
• 에코시스템 시장 매핑
• 사례 연구 분석
• Porter's Five Forces 분석
• 규제 분석
• 특허 분석
• 참고 가격 모델 분석
• 주요 컨퍼런스와 이벤트
• 주요 이해관계자·구입 기준

제7장 유방 병변 위치결정 시장 : 유형별

• 와이어
• 방사성 동위체
• 자기
• 전자
• 기타

제8장 유방 병변 위치결정 시장 : 용도별

• 유방 생검
• 유방 온존(유방절제술)

제9장 유방 병변 위치결정 시장 : 최종사용자별

• 병원·진료소
• 영상 진단 센터
• 외래 수술 센터
• 기타

제10장 유방 병변 위치결정 시장 : 지역별

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제11장 경쟁 구도

• 주요 기업의 매출 점유율 분석
• 시장 점유율 분석
• 기업 평가 매트릭스
• 스타트업 기업의 기업 평가 매트릭스
• 기업의 제품 발자국
• 주요 기업의 지역 발자국
• 경쟁 벤치마킹
• 경쟁 구도·동향
• 유방 병변 위치결정 방법 : 비교 분석 방법
• 유방 병변 위치결정 방법 : 선택 기준 평가
• 교체 동향의 정성적 평가

제12장 기업 개요

• 주요 기업
  • HOLOGIC, INC.
  • BECTON, DICKINSON AND COMPANY
  • MERIT MEDICAL SYSTEMS
  • LEICA BIOSYSTEMS NUSSLOCH GMBH
  • ARGON MEDICAL DEVICES
  • LAURANE MEDICAL LLC
  • ENDOMAGNETICS LTD.(ENDOMAG)
  • INTRAMEDICAL IMAGING, LLC
  • ISOAID
  • SURGICEYE GMBH
• 기타 기업
  • RANFAC CORP.
  • MERMAID MEDICAL GROUP
  • IZI MEDICAL PRODUCTS, LLC
  • MATEK MEDIKAL
  • TSUNAMI MEDICAL SRL
  • BPB MEDICA
  • SIRIUS MEDICAL SYSTEMS B.V.
  • MOLLI SURGICAL INC.
  • STERYLAB S.R.L.
  • CP MEDICAL
  • MDL SRL
  • BIOMEDICAL SRL
  • ELUCENT MEDICAL
  • VIGEO SRL
  • MEDAX MEDICAL DEVICES

제13장 부록

KSA

영문 목차

영문목차

The global breast lesion localization market is projected to reach USD 0.4 billion by 2028 from USD 0.3 billion in 2023, at a CAGR of 6.9% during the forecast period. The increasing screening of breast cancer through mammography and the increasing number of improvements in imaging technology have increased the detection of a non-palpable clinically occult breast lesion, which requires perioperative localization.

There have been several technological advancements in breast lesion localization equipment in recent years aimed at improving patient safety, increasing efficiency, and reducing the cost of healthcare.

"Breast biopsy segment accounted for a larger share of the breast lesion localization market"

In 2022, the breast biopsy segment accounted for a larger share of the breast lesion localization market. The large share of this segment can be attributed to the increasing number of patients opting for breast biopsies across the world, the increasing rate of non-palpable breast lesions detected in screening programs, the rising number of breast cancer screening programs, the growing incidence of breast cancer, and an increase in awareness of early cancer detection.

"The electromagnetic localization will grow at highest CAGR during the forecast period"

Based on type, the electromagnetic localization segment is estimated to grow at the highest during the forecast period. The high growth of this segment can be attributed to factors such as reduction in surgical delays, improved patient satisfaction, optimal surgical planning, and no need for radioactive components. A recent development in the field of breast localization methods is the emergence of technologically advanced localization methods, which use electromagnetic waves to localize breast lesions.

"Asia Pacific will grow at highest CAGR during the forecast period"

In 2022, Asia Pacific will grow at highest CAGR during the forecast period. Major factors driving the growth of this market are rising prevalence of breast cancer, increasing healthcare expenditure, and the increasing number of awareness programs for the early detection of breast cancer in several APAC countries. Furthermore, rising government spending on breast cancer research, and growing funding are also driving the market growth in APAC.

The break-up of the profile of primary participants in the breast lesion localization market: Supply-side

• By Company Type: Tier 1 - 55%, Tier 2 - 30%, and Tier 3 - 15%
• By Designation: C Level - 28%, Hospital Director & Managers - 33%, Others-39%
• By Region: North America - 35%, Europe - 20%, Asia Pacific - 30%, Middle East - 9%, and Latin America - 6%

The break-up of the profile of primary participants in the breast lesion localization market: Demand-side

• By End User: Hospitals - 55%, Clinics - 32%, and Ambulatory Surgical Centers - 13%
• By Designation: Doctors - 35%, Hospitals, Directors and Mangers - 27%, Critical Care Specialist-22% Others-16%
• By Region: North America - 17%, Europe - 39%, Asia Pacific - 28%, Middle East - 8%, and Latin America - 8%

The prominent players in the breast lesion localization market include Hologic, Inc. (US), Becton, Dickinson and Company (US), Merit Medical Systems (US), Leica Biosystems Nussloch GmbH (US), Argon Medical Devices (US).

Research Coverage:

The report analyzes the breast lesion localization market and aims at estimating the market size and future growth potential of this market based on various segments such as type, usage, end user and region. The report also includes a product portfolio matrix of various breast lesion localization available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall breast lesion localization market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (increasing incidence of breast cancer, growing rate of the aging population, increasing awareness on the early detection of breast cancer), restraints (uncertainty in regulatory approval procedures), opportunities (emerging economies offer high growth potential and increasing adoption of technologically advanced localization procedures), and challenges (shortage of oncologists) influencing the growth of the breast lesion localization market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the breast lesion localization market
• Market Development: Comprehensive information on the lucrative emerging markets by type, usage, end user and region.
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global breast lesion localization market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players like Hologic, Inc. (US), Becton, Dickinson and Company (US), Merit Medical Systems (US), Leica Biosystems Nussloch GmbH (US), Argon Medical Devices (US) in the global breast lesion localization market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 INCLUSIONS AND EXCLUSIONS
• 1.4 STUDY SCOPE
  • 1.4.1 MARKETS COVERED
  • FIGURE 1 MARKET SEGMENTATION
  • 1.4.2 YEARS CONSIDERED
• 1.5 CURRENCY CONSIDERED
• 1.6 STAKEHOLDERS
• 1.7 SUMMARY OF CHANGES
• 1.8 RECESSION IMPACT: BREAST LESION LOCALIZATION MARKET

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 2 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
  • FIGURE 3 PRIMARY SOURCES
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
• 2.2 MARKET SIZE ESTIMATION
  • FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: HOLOGIC, INC.
  • FIGURE 8 BREAST LESION LOCALIZATION MARKET: REVENUE SHARE ANALYSIS OF FOUR KEY COMPANIES (2022)
  • FIGURE 9 BREAST LESION LOCALIZATION MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.2.1 MARKET SEGMENT ASSESSMENT (BY TYPE, USAGE, AND END USER)
  • FIGURE 11 TOP-DOWN APPROACH
  • 2.2.2 GEOGRAPHICAL MARKET ASSESSMENT (BY REGION AND COUNTRY)
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 12 DATA TRIANGULATION METHODOLOGY
• 2.4 STUDY ASSUMPTIONS
• 2.5 RISK ASSESSMENT
  • TABLE 1 BREAST LESION LOCALIZATION MARKET: RISK ASSESSMENT ANALYSIS
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

• FIGURE 13 BREAST LESION LOCALIZATION MARKET, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES)
• FIGURE 14 BREAST LESION LOCALIZATION MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
• FIGURE 15 RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES)
• FIGURE 16 RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
• FIGURE 17 BREAST LESION LOCALIZATION MARKET, BY USAGE, 2023 VS. 2028 (THOUSAND PROCEDURES)
• FIGURE 18 BREAST LESION LOCALIZATION MARKET, BY USAGE, 2023 VS. 2028 (USD MILLION)
• FIGURE 19 BREAST LESION LOCALIZATION MARKET, BY END USER, 2023 VS. 2028 (THOUSAND PROCEDURES)
• FIGURE 20 BREAST LESION LOCALIZATION MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
• FIGURE 21 GEOGRAPHICAL ANALYSIS: GLOBAL BREAST LESION LOCALIZATION MARKET (PROCEDURES)
• FIGURE 22 GEOGRAPHICAL ANALYSIS: GLOBAL BREAST LESION LOCALIZATION MARKET (VALUE)

4 PREMIUM INSIGHTS

• 4.1 BREAST LESION LOCALIZATION MARKET OVERVIEW
  • FIGURE 23 RISING AWARENESS ABOUT BREAST CANCER AND INCREASING GOVERNMENT INITIATIVES GLOBALLY TO DRIVE MARKET
• 4.2 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE
  • FIGURE 24 WIRE LOCALIZATION HELD LARGEST SHARE OF ASIA PACIFIC BREAST LESION LOCALIZATION MARKET IN 2022
• 4.3 BREAST LESION LOCALIZATION MARKET (BASED ON VALUE): REGIONAL GROWTH OPPORTUNITIES
  • FIGURE 25 ASIA PACIFIC TO WITNESS HIGHEST GROWTH IN BREAST LESION LOCALIZATION MARKET DURING FORECAST PERIOD
• 4.4 BREAST LESION LOCALIZATION MARKET, BY REGION
  • FIGURE 26 NORTH AMERICA TO DOMINATE BREAST LESION LOCALIZATION MARKET TILL 2028
• 4.5 BREAST LESION LOCALIZATION MARKET: DEVELOPED VS. EMERGING ECONOMIES (USD MILLION)
  • FIGURE 27 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 28 BREAST LESION LOCALIZATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing incidence of breast cancer
  • TABLE 2 TOP 10 COUNTRIES WITH HIGHEST INCIDENCE OF BREAST CANCER, 2020
  • FIGURE 29 ESTIMATED GLOBAL NUMBER OF NEW BREAST CANCER CASES (2020-2040)
    • 5.2.1.2 Growth in aging population
    • 5.2.1.3 Increasing awareness on early detection of breast cancer
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Uncertainty in regulatory approval procedures
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 High growth potential in emerging economies
  • FIGURE 30 GDP GROWTH FORECAST: COMPARISON AMONG INDIA, CHINA, US, AND GERMANY, 2020 VS. 2040
    • 5.2.3.2 Increasing adoption of technologically advanced localization procedures
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Shortage of oncologists

6 INDUSTRY INSIGHTS

• 6.1 INDUSTRY TRENDS
  • 6.1.1 ELECTROMAGNETIC WAVES FOR LOCALIZATION OF BREAST LESIONS
  • 6.1.2 RADIOFREQUENCY IDENTIFICATION IN BREAST LESION LOCALIZATION
  • 6.1.3 MACHINE LEARNING ALGORITHMS FOR COMPUTER-AIDED BREAST LESION DETECTION
• 6.2 IMPACT OF ECONOMIC RECESSION ON BREAST LESION LOCALIZATION MARKET
• 6.3 VALUE CHAIN ANALYSIS
  • FIGURE 31 BREAST LESION LOCALIZATION MARKET: VALUE CHAIN ANALYSIS
• 6.4 REIMBURSEMENT ANALYSIS
  • TABLE 3 MEDICARE REIMBURSEMENT FOR BREAST LESION LOCALIZATION METHODS
• 6.5 TECHNOLOGY ANALYSIS
  • 6.5.1 KEY TECHNOLOGIES
    • 6.5.1.1 Wire-guided localization (WL)
    • 6.5.1.2 Carbon marking
    • 6.5.1.3 Radioguided occult lesion localization (ROLL)
    • 6.5.1.4 Radioactive seed localization (RSL)
    • 6.5.1.5 Magnetic seed localization (MSL)
    • 6.5.1.6 Radiofrequency reflector (RFR)
  • 6.5.2 COMPLEMENTARY TECHNOLOGIES
    • 6.5.2.1 Mammography
    • 6.5.2.2 3D mammography or tomosynthesis
    • 6.5.2.3 Magnetic resonance imaging
    • 6.5.2.4 Ultrasound
  • 6.5.3 ADJACENT TECHNOLOGIES
    • 6.5.3.1 Computer vision and artificial intelligence
• 6.6 SUPPLY CHAIN ANALYSIS
  • FIGURE 32 BREAST LESION LOCALIZATION MARKET: SUPPLY CHAIN ANALYSIS
• 6.7 ECOSYSTEM MARKET MAPPING
  • FIGURE 33 BREAST LESION LOCALIZATION MARKET: ECOSYSTEM MARKET MAPPING
• 6.8 CASE STUDY ANALYSIS
  • TABLE 4 CASE STUDY 1: ESTIMATING MARKET SIZE OF BREAST LESION LOCALIZATION METHODS AND MARKET SHARE ANALYSIS FOR KEY PRODUCTS AT COUNTRY LEVEL
  • TABLE 5 CASE STUDY 2: ESTIMATING MARKET SIZE OF BREAST BIOPSY AND MARKET SHARE ANALYSIS FOR KEY PRODUCTS AT COUNTRY LEVEL
• 6.9 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 6 BREAST LESION LOCALIZATION MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 6.9.1 INTENSITY OF COMPETITIVE RIVALRY
  • 6.9.2 BARGAINING POWER OF SUPPLIERS
  • 6.9.3 BARGAINING POWER OF BUYERS
  • 6.9.4 THREAT OF SUBSTITUTES
  • 6.9.5 THREAT OF NEW ENTRANTS
• 6.10 REGULATORY ANALYSIS
  • 6.10.1 NORTH AMERICA
    • 6.10.1.1 US
  • TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • 6.10.1.2 Canada
  • TABLE 9 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 10 CLASSIFICATION OF BREAST LESION LOCALIZATION DEVICES ACCORDING TO GOVERNMENT OF CANADA
  • 6.10.2 EUROPE
  • FIGURE 34 EUROPE: CLASS III MEDICAL DEVICES
  • 6.10.3 ASIA PACIFIC
    • 6.10.3.1 India
• 6.11 PATENT ANALYSIS
  • 6.11.1 PATENT PUBLICATION TRENDS FOR BREAST LESIONS
  • FIGURE 35 PATENT PUBLICATION TRENDS (JANUARY 2013-MAY 2023)
  • 6.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • FIGURE 36 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR BREAST LESION PATENTS (JANUARY 2013-MAY 2023)
  • FIGURE 37 TOP APPLICANT COUNTRIES/REGIONS FOR BREAST LESION PATENTS (JANUARY 2013-MAY 2023)
• 6.12 INDICATIVE PRICING MODEL ANALYSIS
  • TABLE 11 AVERAGE SELLING PRICE OF BREAST LESION LOCALIZATION CONSUMABLES (2023)
  • 6.12.1 AVERAGE SELLING PRICE TRENDS
• 6.13 KEY CONFERENCES AND EVENTS IN 2023-2024
• 6.14 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 6.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 38 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR BREAST LESION LOCALIZATION TYPE
  • TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR BREAST LESION LOCALIZATION TYPE
  • 6.14.2 BUYING CRITERIA
  • FIGURE 39 KEY BUYING CRITERIA FOR BREAST LESION LOCALIZATION
  • TABLE 13 KEY BUYING CRITERIA FOR BREAST LESION LOCALIZATION

7 BREAST LESION LOCALIZATION MARKET, BY TYPE

• 7.1 INTRODUCTION
  • TABLE 14 BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 15 BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
• 7.2 WIRE LOCALIZATION
  • 7.2.1 WIRE LOCALIZATION SEGMENT TO COMMAND LARGEST SHARE OF BREAST LESION LOCALIZATION MARKET
  • TABLE 16 WIRE LOCALIZATION MARKET, BY COUNTRY, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 17 WIRE LOCALIZATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.3 RADIOISOTOPE LOCALIZATION
  • TABLE 18 RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 19 RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 20 RADIOISOTOPE LOCALIZATION MARKET, BY COUNTRY, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 21 RADIOISOTOPE LOCALIZATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3.1 RADIOGUIDED OCCULT LESION LOCALIZATION
    • 7.3.1.1 Radioguided occult lesion localization to result in shorter operating times and higher rates of tumor-free margins
  • TABLE 22 RADIOGUIDED OCCULT LESION LOCALIZATION MARKET, BY COUNTRY, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 23 RADIOGUIDED OCCULT LESION LOCALIZATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3.2 RADIOACTIVE SEED LOCALIZATION
    • 7.3.2.1 Decreased operative time and long half-life of radioactive seed localization to drive segment
  • TABLE 24 RADIOACTIVE SEED LOCALIZATION MARKET, BY COUNTRY, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 25 RADIOACTIVE SEED LOCALIZATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.4 MAGNETIC LOCALIZATION
  • 7.4.1 INCREASED WORKFLOW EFFICIENCY AND COST-EFFECTIVENESS TO DRIVE MARKET
  • TABLE 26 MAGNETIC LOCALIZATION MARKET, BY COUNTRY, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 27 MAGNETIC LOCALIZATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.5 ELECTROMAGNETIC LOCALIZATION
  • 7.5.1 ELECTROMAGNETIC LOCALIZATION TO ENABLE SMALLER INCISIONS DURING SURGERIES
  • TABLE 28 ELECTROMAGNETIC LOCALIZATION MARKET, BY COUNTRY, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 29 ELECTROMAGNETIC LOCALIZATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.6 OTHER LOCALIZATION TYPES
  • TABLE 30 OTHER LOCALIZATION TYPES MARKET, BY COUNTRY, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 31 OTHER LOCALIZATION TYPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

8 BREAST LESION LOCALIZATION MARKET, BY USAGE

• 8.1 INTRODUCTION
  • TABLE 32 BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 33 BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (USD MILLION)
• 8.2 BREAST BIOPSY
  • 8.2.1 GROWING INCIDENCE OF BREAST CANCER TO DRIVE MARKET
  • TABLE 34 BREAST LESION LOCALIZATION MARKET FOR BREAST BIOPSY, BY COUNTRY, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 35 BREAST LESION LOCALIZATION MARKET FOR BREAST BIOPSY, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.3 BREAST CONSERVATION (LUMPECTOMY)
  • 8.3.1 INCREASING ADOPTION OF BREAST CONSERVATION PROCEDURES TO DRIVE MARKET
  • TABLE 36 BREAST LESION LOCALIZATION MARKET FOR BREAST CONSERVATION, BY COUNTRY, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 37 BREAST LESION LOCALIZATION MARKET FOR BREAST CONSERVATION, BY COUNTRY, 2021-2028 (USD MILLION)

9 BREAST LESION LOCALIZATION MARKET, BY END USER

• 9.1 INTRODUCTION
  • TABLE 38 BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 39 BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.2 HOSPITALS AND CLINICS
  • 9.2.1 HOSPITALS TO PERFORM LARGE NUMBER OF BREAST LESION LOCALIZATION PROCEDURES
  • TABLE 40 BREAST LESION LOCALIZATION MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 41 BREAST LESION LOCALIZATION MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2028 (USD MILLION)
• 9.3 DIAGNOSTIC IMAGING CENTERS
  • 9.3.1 INCREASED DEMAND FOR EARLY DIAGNOSIS TO DRIVE MARKET
  • TABLE 42 BREAST LESION LOCALIZATION MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 43 BREAST LESION LOCALIZATION MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
• 9.4 AMBULATORY SURGICAL CENTERS
  • 9.4.1 INCREASING NUMBER OF OUTPATIENT VISITS TO DRIVE MARKET
  • TABLE 44 BREAST LESION LOCALIZATION MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 45 BREAST LESION LOCALIZATION MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
• 9.5 OTHER END USERS
  • TABLE 46 BREAST LESION LOCALIZATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 47 BREAST LESION LOCALIZATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

10 BREAST LESION LOCALIZATION MARKET, BY REGION

• 10.1 INTRODUCTION
  • FIGURE 40 NUMBER OF BREAST CANCER CASES VS. NUMBER OF DEATHS IN 2020 (THOUSANDS)
  • FIGURE 41 BREAST LESION LOCALIZATION MARKET: GEOGRAPHICAL SNAPSHOT
  • TABLE 48 BREAST LESION LOCALIZATION MARKET, BY REGION, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 49 BREAST LESION LOCALIZATION MARKET, BY REGION, 2021-2028 (USD MILLION)
• 10.2 NORTH AMERICA
  • FIGURE 42 NORTH AMERICA: NUMBER OF BREAST CANCER CASES IN 2020 (THOUSANDS)
  • 10.2.1 NORTH AMERICA: RECESSION IMPACT
  • TABLE 50 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 51 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 52 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 53 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 54 NORTH AMERICA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 55 NORTH AMERICA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 56 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 57 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (USD MILLION)
  • TABLE 58 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 59 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.2.2 US
    • 10.2.2.1 High adoption of innovative technologies to drive market
  • TABLE 60 US: KEY MACROINDICATORS
  • TABLE 61 US: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 62 US: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 63 US: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 64 US: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 65 US: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 66 US: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (USD MILLION)
  • TABLE 67 US: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 68 US: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.2.3 CANADA
    • 10.2.3.1 Supportive government initiatives for breast cancer awareness to drive market
  • TABLE 69 CANADA: KEY MACROINDICATORS
  • TABLE 70 CANADA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 71 CANADA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 72 CANADA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 73 CANADA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 74 CANADA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 75 CANADA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (USD MILLION)
  • TABLE 76 CANADA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 77 CANADA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (USD MILLION)
• 10.3 EUROPE
  • FIGURE 44 EUROPE: NUMBER OF BREAST CANCER CASES IN 2020 (THOUSANDS)
  • 10.3.1 EUROPE: RECESSION IMPACT
  • TABLE 78 EUROPE: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 79 EUROPE: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 80 EUROPE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 81 EUROPE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 82 EUROPE: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 83 EUROPE: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 84 EUROPE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 85 EUROPE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (USD MILLION)
  • TABLE 86 EUROPE: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 87 EUROPE: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.2 GERMANY
    • 10.3.2.1 Favorable reimbursement policies for healthcare procedures to drive market
  • TABLE 88 GERMANY: KEY MACROINDICATORS
  • TABLE 89 GERMANY: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 90 GERMANY: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 91 GERMANY: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 92 GERMANY: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 93 GERMANY: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 94 GERMANY: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (USD MILLION)
  • TABLE 95 GERMANY: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 96 GERMANY: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.3 FRANCE
    • 10.3.3.1 Rising incidences of breast cancer among aged women to drive market
  • TABLE 97 FRANCE: KEY MACROINDICATORS
  • TABLE 98 FRANCE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 99 FRANCE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 100 FRANCE: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 101 FRANCE: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 102 FRANCE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 103 FRANCE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (USD MILLION)
  • TABLE 104 FRANCE: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 105 FRANCE: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.4 UK
    • 10.3.4.1 Increasing public-private initiatives for breast cancer awareness to drive market
  • TABLE 106 UK: KEY MACROINDICATORS
  • TABLE 107 UK: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 108 UK: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 109 UK: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 110 UK: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 111 UK: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 112 UK: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (USD MILLION)
  • TABLE 113 UK: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 114 UK: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.5 ITALY
    • 10.3.5.1 Increasing demand for breast lesion localization systems to drive market
  • TABLE 115 ITALY: KEY MACROINDICATORS
  • TABLE 116 ITALY: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 117 ITALY: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 118 ITALY: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 119 ITALY: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 120 ITALY: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 121 ITALY: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (USD MILLION)
  • TABLE 122 ITALY: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 123 ITALY: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.6 SPAIN
    • 10.3.6.1 Growing access to advanced cancer screening programs to drive market
  • TABLE 124 SPAIN: KEY MACROINDICATORS
  • TABLE 125 SPAIN: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 126 SPAIN: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 127 SPAIN: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 128 SPAIN: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 129 SPAIN: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 130 SPAIN: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (USD MILLION)
  • TABLE 131 SPAIN: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 132 SPAIN: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.7 REST OF EUROPE
  • TABLE 133 REST OF EUROPE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 134 REST OF EUROPE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 135 REST OF EUROPE: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 136 REST OF EUROPE: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 137 REST OF EUROPE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 138 REST OF EUROPE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (USD MILLION)
  • TABLE 139 REST OF EUROPE: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 140 REST OF EUROPE: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (USD MILLION)
• 10.4 ASIA PACIFIC
  • FIGURE 46 ASIA PACIFIC: NUMBER OF BREAST CANCER CASES, 2020 (IN THOUSANDS)
  • 10.4.1 ASIA PACIFIC: RECESSION IMPACT
  • TABLE 141 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 142 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 144 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 146 ASIA PACIFIC: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 148 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 150 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4.2 CHINA
    • 10.4.2.1 Increasing patient pool and developing government healthcare initiatives to drive market
  • TABLE 151 CHINA: KEY MACROINDICATORS
  • TABLE 152 CHINA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 153 CHINA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 154 CHINA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 155 CHINA: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 156 CHINA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 157 CHINA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (USD MILLION)
  • TABLE 158 CHINA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 159 CHINA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4.3 JAPAN
    • 10.4.3.1 Increasing number of universal healthcare reimbursement policies to drive market
  • TABLE 160 JAPAN: KEY MACROINDICATORS
  • TABLE 161 JAPAN: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 162 JAPAN: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 163 JAPAN: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 164 JAPAN: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 165 JAPAN: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 166 JAPAN: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (USD MILLION)
  • TABLE 167 JAPAN: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 168 JAPAN: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4.4 INDIA
    • 10.4.4.1 Increasing government Initiatives for female health improvement to drive market
  • TABLE 169 INDIA: KEY MACROINDICATORS
  • TABLE 170 INDIA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 171 INDIA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 172 INDIA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 173 INDIA: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 174 INDIA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 175 INDIA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (USD MILLION)
  • TABLE 176 INDIA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 177 INDIA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Growing breast cancer awareness campaigns by public and private organizations to drive market
  • TABLE 178 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 179 AUSTRALIA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 180 AUSTRALIA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 181 AUSTRALIA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 182 AUSTRALIA: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 183 AUSTRALIA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 184 AUSTRALIA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (USD MILLION)
  • TABLE 185 AUSTRALIA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 186 AUSTRALIA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 Growing government awareness campaigns and rising incidences of breast cancer to drive market
  • TABLE 187 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 188 SOUTH KOREA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 189 SOUTH KOREA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 190 SOUTH KOREA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 191 SOUTH KOREA: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 192 SOUTH KOREA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 193 SOUTH KOREA: BREAST LESION LOCALIZATION PRODUCTS MARKET, BY USAGE, 2021-2028 (USD MILLION)
  • TABLE 194 SOUTH KOREA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 195 SOUTH KOREA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4.7 REST OF ASIA PACIFIC
  • TABLE 196 REST OF ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 197 REST OF ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 198 REST OF ASIA PACIFIC: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 199 REST OF ASIA PACIFIC: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 200 REST OF ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 201 REST OF ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (USD MILLION)
  • TABLE 202 REST OF ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 203 REST OF ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (USD MILLION)
• 10.5 LATIN AMERICA
  • 10.5.1 RISING GERIATRIC POPULATION AND PRESENCE OF FAVORABLE REGULATORY ENVIRONMENT TO DRIVE MARKET
  • 10.5.2 LATIN AMERICA: RECESSION IMPACT
  • TABLE 204 LATIN AMERICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 205 LATIN AMERICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 206 LATIN AMERICA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 207 LATIN AMERICA: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 208 LATIN AMERICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 209 LATIN AMERICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (USD MILLION)
  • TABLE 210 LATIN AMERICA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 211 LATIN AMERICA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (USD MILLION)
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 RISING GOVERNMENT INVESTMENTS AND INCREASING BREAST CANCER AWARENESS PROGRAMS TO DRIVE MARKET
  • 10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
  • TABLE 212 MIDDLE EAST & AFRICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 213 MIDDLE EAST & AFRICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 214 MIDDLE EAST & AFRICA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 215 MIDDLE EAST & AFRICA: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 216 MIDDLE EAST & AFRICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 217 MIDDLE EAST & AFRICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021-2028 (USD MILLION)
  • TABLE 218 MIDDLE EAST & AFRICA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (THOUSAND PROCEDURES)
  • TABLE 219 MIDDLE EAST & AFRICA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021-2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
  • FIGURE 48 KEY DEVELOPMENTS IN BREAST LESION LOCALIZATION MARKET
• 11.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
  • FIGURE 49 BREAST LESION LOCALIZATION MARKET: REVENUE ANALYSIS OF KEY PLAYERS (2018-2022)
• 11.3 MARKET SHARE ANALYSIS
  • FIGURE 50 MARKET SHARE ANALYSIS OF KEY PLAYERS (2022)
• 11.4 COMPANY EVALUATION MATRIX
  • 11.4.1 STARS
  • 11.4.2 EMERGING LEADERS
  • 11.4.3 PERVASIVE PLAYERS
  • 11.4.4 PARTICIPANTS
  • FIGURE 51 BREAST LESION LOCALIZATION MARKET: COMPANY EVALUATION MATRIX, 2022
• 11.5 COMPANY EVALUATION MATRIX FOR START-UPS
  • 11.5.1 PROGRESSIVE COMPANIES
  • 11.5.2 DYNAMIC COMPANIES
  • 11.5.3 STARTING BLOCKS
  • 11.5.4 RESPONSIVE COMPANIES
  • FIGURE 52 BREAST LESION LOCALIZATION MARKET: COMPANY EVALUATION MATRIX FOR START-UPS (2022)
• 11.6 COMPANY PRODUCT FOOTPRINT
  • TABLE 220 BREAST LESION LOCALIZATION MARKET: PRODUCT PORTFOLIO ANALYSIS
• 11.7 REGIONAL FOOTPRINT OF MAJOR PLAYERS IN BREAST LESION LOCALIZATION MARKET
  • TABLE 221 BREAST LESION LOCALIZATION MARKET: GEOGRAPHICAL REVENUE MIX
• 11.8 COMPETITIVE BENCHMARKING
  • TABLE 222 BREAST LESION LOCALIZATION MARKET: KEY START-UPS
• 11.9 COMPETITIVE SITUATIONS AND TRENDS
  • 11.9.1 KEY PRODUCT LAUNCHES
  • TABLE 223 BREAST LESION LOCALIZATION MARKET: KEY PRODUCT LAUNCHES (2020-2023)
  • 11.9.2 KEY DEALS
  • TABLE 224 KEY DEALS (2020-2021)
• 11.10 BREAST LESION LOCALIZATION METHODS: COMPARATIVE ANALYSIS
• 11.11 BREAST LESION LOCALIZATION METHODS: COMPARATIVE ANALYSIS
  • FIGURE 53 COMPARATIVE ANALYSIS: DETECTION RATE, SUCCESS RATE, AND RE-EXCISION RATE
• 11.12 BREAST LESION LOCALIZATION METHODS: SELECTION CRITERIA EVALUATION
  • FIGURE 54 SELECTION CRITERIA EVALUATION
• 11.13 QUALITATIVE ASSESSMENT OF REPLACEMENT TRENDS
  • FIGURE 55 REPLACEMENT TRENDS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
• (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
• 12.1.1 HOLOGIC, INC.
• TABLE 225 HOLOGIC, INC.: COMPANY OVERVIEW
• FIGURE 56 HOLOGIC, INC.: COMPANY SNAPSHOT (2022)
• 12.1.2 BECTON, DICKINSON AND COMPANY
• TABLE 226 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
• FIGURE 57 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
• 12.1.3 MERIT MEDICAL SYSTEMS
• TABLE 227 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW
• FIGURE 58 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2022)
• 12.1.4 LEICA BIOSYSTEMS NUSSLOCH GMBH
• TABLE 228 DANAHER: COMPANY OVERVIEW
• FIGURE 59 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
• 12.1.5 ARGON MEDICAL DEVICES
• TABLE 229 ARGON MEDICAL DEVICES: COMPANY OVERVIEW
• 12.1.6 LAURANE MEDICAL LLC
• TABLE 230 LAURANE MEDICAL LLC: COMPANY OVERVIEW
• 12.1.7 ENDOMAGNETICS LTD. (ENDOMAG)
• TABLE 231 ENDOMAGNETICS LIMITED: COMPANY OVERVIEW
• 12.1.8 INTRAMEDICAL IMAGING, LLC
• TABLE 232 INTRAMEDICAL IMAGING, LLC: COMPANY OVERVIEW
• 12.1.9 ISOAID
• TABLE 233 ISOAID: COMPANY OVERVIEW
• 12.1.10 SURGICEYE GMBH
• TABLE 234 SURGICEYE GMBH: COMPANY OVERVIEW
• 12.2 OTHER PLAYERS
  • 12.2.1 RANFAC CORP.
  • TABLE 235 RANFAC CORP.: COMPANY OVERVIEW
  • 12.2.2 MERMAID MEDICAL GROUP
  • TABLE 236 MERMAID MEDICAL GROUP: COMPANY OVERVIEW
  • 12.2.3 IZI MEDICAL PRODUCTS, LLC
  • TABLE 237 IZI MEDICAL PRODUCTS, LLC: COMPANY OVERVIEW
  • 12.2.4 MATEK MEDIKAL
  • TABLE 238 MATEK MEDIKAL: COMPANY OVERVIEW
  • 12.2.5 TSUNAMI MEDICAL SRL
  • TABLE 239 TSUNAMI MEDICAL SRL: COMPANY OVERVIEW
  • 12.2.6 BPB MEDICA
  • TABLE 240 BPB MEDICA: COMPANY OVERVIEW
  • 12.2.7 SIRIUS MEDICAL SYSTEMS B.V.
  • TABLE 241 SIRIUS MEDICAL SYSTEMS B.V.: COMPANY OVERVIEW
  • 12.2.8 MOLLI SURGICAL INC.
  • TABLE 242 MOLLI SURGICAL INC.: COMPANY OVERVIEW
  • 12.2.9 STERYLAB S.R.L.
  • TABLE 243 STERYLAB S.R.L.: COMPANY OVERVIEW
  • 12.2.10 CP MEDICAL
  • TABLE 244 CP MEDICAL: COMPANY OVERVIEW
  • 12.2.11 MDL SRL
  • TABLE 245 MDL SRL: COMPANY OVERVIEW
  • 12.2.12 BIOMEDICAL SRL
  • TABLE 246 BIOMEDICAL SRL: COMPANY OVERVIEW
  • 12.2.13 ELUCENT MEDICAL
  • TABLE 247 ELUCENT MEDICAL: COMPANY OVERVIEW
  • 12.2.14 VIGEO SRL
  • TABLE 248 VIGEO SRL: COMPANY OVERVIEW
  • 12.2.15 MEDAX MEDICAL DEVICES
  • TABLE 249 MEDAX MEDICAL DEVICES: COMPANY OVERVIEW
• *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 RELATED REPORTS
• 13.4 AUTHOR DETAILS

관련자료